InVivo Therapeutics Holdings Corp. (NASDAQOTH:NVIV)

CAPS Rating: 3 out of 5

Results 1 - 4 of 4

Recs

0
Member Avatar bcellars (63.97) Submitted: 11/15/2013 1:55:39 PM : Outperform Start Price: $2.38 NVIV Score: -66.13

Wow... meant to pick this earlier today before it suddenly popped 55%!!

Recs

0
Member Avatar 007mercucio (30.96) Submitted: 9/12/2013 10:37:30 AM : Outperform Start Price: $1.44 NVIV Score: -50.22

cured monkeys of spinal damage induced paralysis - next step, humans
stock at an all time low
heavy accumulation indicates possible buyout target

Recs

0
Member Avatar kentinc (55.69) Submitted: 5/13/2013 2:38:49 PM : Outperform Start Price: $2.94 NVIV Score: -86.76

The big IF is successfully navigating clinical human trials. If it does so then this has massive upside potential.

Recs

0
Member Avatar holytea7 (< 20) Submitted: 3/18/2013 9:45:48 PM : Outperform Start Price: $2.31 NVIV Score: -84.51

Next Top Dog and First Mover in medical device company.

Results 1 - 4 of 4

Featured Broker Partners


Advertisement